Tue, October 17, 2023

Rick Bienkowski Maintained (BEAM) at Buy with Decreased Target to $32 on, Oct 17th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-decreased-target-to-32-on-oct-17th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
  • 🞛 This publication is a summary or evaluation of another publication
  • 🞛 This publication contains potentially derogatory content such as foul language or violent themes
Rick Bienkowski of Cantor Fitzgerald, Maintained "Beam Therapeutics Inc." (BEAM) at Buy with Decreased Target from $56 to $32 on, Oct 17th, 2023.

Rick has made no other calls on BEAM in the last 4 months.



There are 3 other peers that have a rating on BEAM. Out of the 3 peers that are also analyzing BEAM, 2 agree with Rick's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Gena Wang of "Barclays" Maintained at Hold with Decreased Target to $35 on, Wednesday, August 9th, 2023
  • Richard Law of "Credit Suisse" Maintained at Hold with Increased Target to $47 on, Wednesday, August 9th, 2023


This is the rating of the analyst that currently disagrees with Rick


  • Samantha Semenkow of "Citigroup" Maintained at Strong Buy with Decreased Target to $56 on, Wednesday, August 9th, 2023